Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
3121
PCAECG-GAN K-fold experiment table.
Published 2025“…Experiments demonstrate that PCA-CGAN not only achieves stable convergence on a large-scale heterogeneous dataset comprising 43 patients for the first time but also resolves the “dilution effect” problem in data augmentation, avoiding the asymmetric phenomenon where Precision increases while Recall decreases. After data augmentation, the ResNet model’s average F1 score improved significantly, with particularly outstanding performance on rare categories such as atrial premature beats, far surpassing traditional methods like SigCWGAN and TD-GAN. …”
-
3122
PCA-CGAN Pseudocode Table.
Published 2025“…Experiments demonstrate that PCA-CGAN not only achieves stable convergence on a large-scale heterogeneous dataset comprising 43 patients for the first time but also resolves the “dilution effect” problem in data augmentation, avoiding the asymmetric phenomenon where Precision increases while Recall decreases. After data augmentation, the ResNet model’s average F1 score improved significantly, with particularly outstanding performance on rare categories such as atrial premature beats, far surpassing traditional methods like SigCWGAN and TD-GAN. …”
-
3123
PCA-CGAN Ablation Experiment Results.
Published 2025“…Experiments demonstrate that PCA-CGAN not only achieves stable convergence on a large-scale heterogeneous dataset comprising 43 patients for the first time but also resolves the “dilution effect” problem in data augmentation, avoiding the asymmetric phenomenon where Precision increases while Recall decreases. After data augmentation, the ResNet model’s average F1 score improved significantly, with particularly outstanding performance on rare categories such as atrial premature beats, far surpassing traditional methods like SigCWGAN and TD-GAN. …”
-
3124
Gene expression of neurotransmitter pathways at 6 dp.
Published 2025“…In the 24 hpf dnVDRa induced group we see a significant decrease in glyt1 expression (p < 0.05) and an increase in glyt2 expression (p < 0.05) and in slc32a1 expression (p < 0.01). …”
-
3125
PCAIs inhibit NCI-H23 cell line viability.
Published 2024“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”
-
3126
PCAIs disrupt actin filaments in NCI-H23 cells.
Published 2024“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”
-
3127
PCAIs suppress 3D NCI-H23 cell invasion.
Published 2024“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”
-
3128
PCAIs suppress NCI-H23 cancer cell migration.
Published 2024“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”
-
3129
PCAIs induce apoptosis in NCI-H23 cells.
Published 2024“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”
-
3130
-
3131
Validation of the optimum formula.
Published 2025“…<div><p>The goal of this study was the formulation and optimization by statistical means of bilosomal formulations of axitinib (AXT) in order to improve its anticancer efficacy in a targeted manner. …”
-
3132
-
3133
-
3134
-
3135
Parameters of VMR separated by light or dark periods run at 6 dpf.
Published 2025“…(I-K) VMR parameters in dnVDRa induced zebrafish at 72 hpf. There is a significant decrease in distance moved (p < 0.05), a significant decrease in velocity the light period (p < 0.05) and a significant decrease in activity state in the light periods (p < 0.05) in the 72 + fish. …”
-
3136
-
3137
-
3138
Visual motor response assay at 28 dpf.
Published 2025“…There is a significant decrease in distance moved in the dark period (p < 0.05), a significant decrease in velocity in the dark (p < 0.05) and light (p < 0.01) periods, a significant decrease in activity state in the dark period (p < 0.001) and light period (p < 0.01) and a significant decrease in distance to point in the dark period (p < 0.05) and light period (p < 0.05) in the 48 + fish. …”
-
3139
-
3140